BNET Industries
Integra LifeSciences Holdings Corp. (IART) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $550.4M
- Profit
- Dec 31 2007
- $33.4M
- Market Cap
- Sep 04 2008
- $1.2B
Latest News and Analysis
Integra LifeSciences Holdings Corp. Q4 2007 Earnings Call Transcript
Integra LifeSciences Holdings Corp. Q4 2007 Earnings Call Transcript
Additional Resources
Examine the World Biocompatible Materials Market
Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Biocompatible Materials Market http://www.reportlinker.com/p090557/World-Biocompatible-Materials-Market.html This report analyzes the worldwide markets for Biocompatible Materials in Millions of US$. The specific product segments analyzed are...
IART, IRBT, LULU, NEON, RICK, SCON Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days.
M2 PRESSWIRE-31 March 2008-BUYINS.NET: IART, IRBT, LULU, NEON, RICK, SCON Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading DaysC1994-2008 M2 COMMUNICATIONS LTD RDATE:31032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been on the...
FSBK, GROW, IART, IPSU, IRBT, LULU Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-12 March 2008-BUYINS.NET: FSBK, GROW, IART, IPSU, IRBT, LULU Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and...
"Integra LifeSciences Holdings Corporation Strategic Analysis Profile" by Global Markets Direct January 2008.
M2 PRESSWIRE-28 January 2008-MarketResearch.com: "Integra LifeSciences Holdings Corporation Strategic Analysis Profile" by Global Markets Direct January 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:24012008 This profile is an essential source for data, analysis and strategic insight into this company. The report examines...
A Financial And Operational Overview Of Integra Lifesciences Holdings Corporation Is Contained In This Detailed Report.
M2 PRESSWIRE-17 January 2008-Research and Markets: A Financial And Operational Overview Of Integra Lifesciences Holdings Corporation Is Contained In This Detailed ReportC1994-2008 M2 COMMUNICATIONS LTD RDATE:17012008 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c79813) has announced the addition of "Integra...
A Financial and Operational Overview of Integra LifeSciences Holdings Corporation is Contained in This Detailed Report
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79812) has announced the addition of "Integra LifeSciences Holdings Corporation Strategic Analysis Profile" to their offering. This profile is an essential source for data, analysis and strategic insight into this company. The report examines Integra LifeSciences Holdings Corporation's business structure and operations,...
Majority of IsoTis Stockholders Vote for Integra Acquisition.
IRVINE, California, October 29 /PRNewswire/ -- IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that, at the special meeting of stockholders re-convened earlier today, IsoTis stockholders have approved the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ...
IsoTis Reports Status of Merger Vote.
IRVINE, California, October 26 /PRNewswire/ -- - Less than 100,000 Additional "FOR" Votes Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today reported that less than 100,000 votes "FOR" are needed to approve the acquisition...
IsoTis Adjourns Special Meeting to October 29, 2007.
IRVINE, California, October 26 /PRNewswire/ -- - Less Than 40,000 Additional "FOR" Votes Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned its special meeting of stockholders again, to Monday,...
Find your Competitors' SWOT Analysis Among More Than 300 Company Profiles
LYON, France -- Reportlinker.com announces that new SWOT analyses related to more than 300 worldwide companies are available in its catalogue. To order those reports, query company name on: www.reportlinker.com/p061971/PRBW-SWOT-Ford-Motor.html For more information, contact Nicolas by email nbo@reportlinker.com , or by...
IsoTis Adjourns Special Meeting to October 26, 2007.
IRVINE, California, October 24 /PRNewswire/ -- - Less Than 350,000 Additional Votes "FOR" Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned the special meeting of stockholders again, to October...
IsoTis Reports Interim Results of Vote for Integra Merger.(Financial report)
IRVINE, California, October 16 /PRNewswire/ -- - Conference Calls to Answer Questions About Stockholder Meeting October 23 IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced the interim tabulation results of the special stockholders meeting held on October...
IsoTis Adjourns Special Meeting to October 23, 2007.
IRVINE, California, October 11 /PRNewswire/ -- IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned the special meeting of stockholders it called to approve the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant...
TomoTherapy and Integra Radionics Partner to Develop a Suite of Stereotactic Fixation Products for the Hi-Art® Treatment System
MADISON, Wis. -- TomoTherapy Incorporated (NASDAQ: TTPY) announced today that it has partnered with Integra Radionics, Inc., a subsidiary of Integra LifeSciences Holdings Corporation (NASDAQ: IART), to develop and distribute the InterFix[TM] radiosurgery kit. The kit includes a suite of fixation products that have been adapted for...
High Growth Forecasted in the Uro-Gynecological Surgical Devices Industry
LYON, France -- Reportlinker.com announces that a new market research report related to the Worldwide medical industry is now available to its catalogue. Uro-Gynecological Surgical Devices www.reportlinker.com/p059662/Uro-Gynecological-Surgical -Devices.html (Due to its length, this URL may need to be copied/pasted into your...
IsoTis - Integra Merger.
IRVINE, California, September 19 /PRNewswire/ -- - Leading Proxy Advisor Recommends Shareholders Support Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that Institutional Shareholder Services, ISS, a leading proxy advisor, recommends shareholders support the merger of ...
First Albany Capital to Host Regenerative Technologies Conference
Conference will delve into industry and specific company growth drivers for the near term and what new technologies are on the horizon across the spectrum of medical specialties NEW YORK -- First Albany Capital Inc., the broker/dealer subsidiary of First Albany Companies Inc. (NASDAQ: FACT),...
IsoTis Files Definitive Proxy Statement.
IRVINE, California, September 5 /PRNewswire/ -- - Special Stockholders Meeting to Approve Merger With Integra on October 11, 2007 IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced the filing of a definitive proxy statement with the U.S....
Integra, IsoTis join forces.(INDUSTRY NEWS)
Integra LifeSciences Holdings Corp and IsoTis Inc have agreed to combine their operations, with the acquisition by Integra of the Swiss company in an all-cash transaction. Under the terms of the agreement, IsoTis will become a wholly owned subsidiary of Integra, making Integra...
- Next »
- page 1 of 1
- « Previous
Sort byClose
- Incorporated: 1989
- CEO: Dr. Stuart M. Essig Ph.D.
Integra LifeSciences Holdings is in regenerative medicine, Co. is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Co.'s products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery. Co. sells its products directly through various sales forces and through a variety of other distribution channels.
Key Competitors
Integra LifeSciences Holdings Corp. Company Info
Board of Directors
Dr. Richard E. Caruso Ph.D.
Chairman
Mr. Thomas J. Baltimore Jr.
Dr. Keith Bradley Ph.D.
Dr. Stuart M. Essig Ph.D.
Mr. Christian S. Schade
Mr. James M. Sullivan
Ms. Anne M. VanLent
Contact Information
311 Enterprise Drive
Plainsboro, NJ
609 275-0500